Analyst Derik De Bruin works at BAML and is focused on Healthcare, Basic Materials sectors with 361 price targets and ratings documented since 2012 spanning on 27 stocks. Analyst's average stock valuation to be materialised ratio is 80.09% with an average time for price targets to be met of 121.7 days.
Most recent stock forecast was given on TX, Ternium S.A at 23-Jan-2023.
Derik De Bruin best performing recommendations are on DNA.
The best stock recommendation documented was for DNA at 1/28/2022. The price target of $6 was fulfilled within 4 days with a profit of $1.03 (20.72%) receiving and performance score of 51.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
250
4 days ago
6/7 (85.71%)
$40.14 (14.27%)
178
Buy
300
$85.97 (40.17%)
330
12 days ago
0/10 (0%)
$147.93 (63.02%)
Buy
300
$85.97 (40.17%)
320
2 months 15 days ago
2/9 (22.22%)
$91.84 (39.00%)
123
Hold
225
$10.97 (5.13%)
240
2 months 22 days ago
3/5 (60%)
$49.92 (19.11%)
75
Hold
225
$10.97 (5.13%)
230
2 months 25 days ago
17/17 (100%)
$-7.03 (-0.65%)
209
